Global Atropine Sulfate Injection Market Growth 2026-2032

April 2026 | 128 pages | ID: G079D28A2561EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Atropine Sulfate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Atropine Sulfate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Atropine Sulfate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Atropine Sulfate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Atropine Sulfate Injection players cover Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Atropine Sulfate Injection Industry Forecast? looks at past sales and reviews total world Atropine Sulfate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Atropine Sulfate Injection sales for 2026 through 2032. With Atropine Sulfate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atropine Sulfate Injection industry.

This Insight Report provides a comprehensive analysis of the global Atropine Sulfate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atropine Sulfate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Atropine Sulfate Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atropine Sulfate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atropine Sulfate Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Atropine Sulfate Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 0.5 mg/mL
  • 1 mg/ml
  • 5 mg/ml
  • Other
Segmentation by Application:
  • Online Sales
  • Offline Sales
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • American Regent
  • Hikma Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Accord Healthcare
  • China Res Double-Crane
  • Hebei Kaiwei Pharmaceutical
  • Hebei Tiancheng Pharmaceutical
  • Tai Yu Chemical & Pharmaceutical
  • Tianjin Jinyao Pharmaceutical
  • Sunflower Pharmaceutical
  • China Shineway Pharm
  • CSPC Ouyi Pharmaceutical
  • Suicheng Pharmaceutical
  • Chengdu Brilliant Pharmaceutical
  • Anhui Changjiang Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • Hubei Xinghua Pharmaceutical
  • Changzhou Pharmaceutical Factory
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Atropine Sulfate Injection market?
  • What factors are driving Atropine Sulfate Injection market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Atropine Sulfate Injection market opportunities vary by end market size?
  • How does Atropine Sulfate Injection break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atropine Sulfate Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Atropine Sulfate Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Atropine Sulfate Injection by Country/Region, 2021, 2025 & 2032
2.2 Atropine Sulfate Injection Segment by Type
  2.2.1 0.5 mg/mL
  2.2.2 1 mg/ml
  2.2.3 5 mg/ml
  2.2.4 Other
  2.2.5 Atropine Sulfate Injection Sales by Type
    2.2.5.1 Global Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Atropine Sulfate Injection Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Atropine Sulfate Injection Sale Price by Type (2021-2026)
2.3 Atropine Sulfate Injection Segment by Application
  2.3.1 Online Sales
  2.3.2 Offline Sales
  2.3.3 Atropine Sulfate Injection Sales by Application
    2.3.3.1 Global Atropine Sulfate Injection Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Atropine Sulfate Injection Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Atropine Sulfate Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Atropine Sulfate Injection Breakdown Data by Company
  3.1.1 Global Atropine Sulfate Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Atropine Sulfate Injection Sales Market Share by Company (2021-2026)
3.2 Global Atropine Sulfate Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Atropine Sulfate Injection Revenue by Company (2021-2026)
  3.2.2 Global Atropine Sulfate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Atropine Sulfate Injection Sale Price by Company
3.4 Key Manufacturers Atropine Sulfate Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Atropine Sulfate Injection Product Location Distribution
  3.4.2 Players Atropine Sulfate Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ATROPINE SULFATE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Atropine Sulfate Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Atropine Sulfate Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Atropine Sulfate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Atropine Sulfate Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Atropine Sulfate Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Atropine Sulfate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Atropine Sulfate Injection Sales Growth
4.4 APAC Atropine Sulfate Injection Sales Growth
4.5 Europe Atropine Sulfate Injection Sales Growth
4.6 Middle East & Africa Atropine Sulfate Injection Sales Growth

5 AMERICAS

5.1 Americas Atropine Sulfate Injection Sales by Country
  5.1.1 Americas Atropine Sulfate Injection Sales by Country (2021-2026)
  5.1.2 Americas Atropine Sulfate Injection Revenue by Country (2021-2026)
5.2 Americas Atropine Sulfate Injection Sales by Type (2021-2026)
5.3 Americas Atropine Sulfate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atropine Sulfate Injection Sales by Region
  6.1.1 APAC Atropine Sulfate Injection Sales by Region (2021-2026)
  6.1.2 APAC Atropine Sulfate Injection Revenue by Region (2021-2026)
6.2 APAC Atropine Sulfate Injection Sales by Type (2021-2026)
6.3 APAC Atropine Sulfate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Atropine Sulfate Injection by Country
  7.1.1 Europe Atropine Sulfate Injection Sales by Country (2021-2026)
  7.1.2 Europe Atropine Sulfate Injection Revenue by Country (2021-2026)
7.2 Europe Atropine Sulfate Injection Sales by Type (2021-2026)
7.3 Europe Atropine Sulfate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atropine Sulfate Injection by Country
  8.1.1 Middle East & Africa Atropine Sulfate Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Atropine Sulfate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Atropine Sulfate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Atropine Sulfate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atropine Sulfate Injection
10.3 Manufacturing Process Analysis of Atropine Sulfate Injection
10.4 Industry Chain Structure of Atropine Sulfate Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Atropine Sulfate Injection Distributors
11.3 Atropine Sulfate Injection Customer

12 WORLD FORECAST REVIEW FOR ATROPINE SULFATE INJECTION BY GEOGRAPHIC REGION

12.1 Global Atropine Sulfate Injection Market Size Forecast by Region
  12.1.1 Global Atropine Sulfate Injection Forecast by Region (2027-2032)
  12.1.2 Global Atropine Sulfate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Atropine Sulfate Injection Forecast by Type (2027-2032)
12.7 Global Atropine Sulfate Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Atropine Sulfate Injection Product Portfolios and Specifications
  13.1.3 Pfizer Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 American Regent
  13.2.1 American Regent Company Information
  13.2.2 American Regent Atropine Sulfate Injection Product Portfolios and Specifications
  13.2.3 American Regent Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 American Regent Main Business Overview
  13.2.5 American Regent Latest Developments
13.3 Hikma Pharmaceuticals
  13.3.1 Hikma Pharmaceuticals Company Information
  13.3.2 Hikma Pharmaceuticals Atropine Sulfate Injection Product Portfolios and Specifications
  13.3.3 Hikma Pharmaceuticals Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Hikma Pharmaceuticals Main Business Overview
  13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Apotex
  13.4.1 Apotex Company Information
  13.4.2 Apotex Atropine Sulfate Injection Product Portfolios and Specifications
  13.4.3 Apotex Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Apotex Main Business Overview
  13.4.5 Apotex Latest Developments
13.5 Amneal Pharmaceuticals
  13.5.1 Amneal Pharmaceuticals Company Information
  13.5.2 Amneal Pharmaceuticals Atropine Sulfate Injection Product Portfolios and Specifications
  13.5.3 Amneal Pharmaceuticals Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Amneal Pharmaceuticals Main Business Overview
  13.5.5 Amneal Pharmaceuticals Latest Developments
13.6 Accord Healthcare
  13.6.1 Accord Healthcare Company Information
  13.6.2 Accord Healthcare Atropine Sulfate Injection Product Portfolios and Specifications
  13.6.3 Accord Healthcare Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Accord Healthcare Main Business Overview
  13.6.5 Accord Healthcare Latest Developments
13.7 China Res Double-Crane
  13.7.1 China Res Double-Crane Company Information
  13.7.2 China Res Double-Crane Atropine Sulfate Injection Product Portfolios and Specifications
  13.7.3 China Res Double-Crane Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 China Res Double-Crane Main Business Overview
  13.7.5 China Res Double-Crane Latest Developments
13.8 Hebei Kaiwei Pharmaceutical
  13.8.1 Hebei Kaiwei Pharmaceutical Company Information
  13.8.2 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Hebei Kaiwei Pharmaceutical Main Business Overview
  13.8.5 Hebei Kaiwei Pharmaceutical Latest Developments
13.9 Hebei Tiancheng Pharmaceutical
  13.9.1 Hebei Tiancheng Pharmaceutical Company Information
  13.9.2 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Hebei Tiancheng Pharmaceutical Main Business Overview
  13.9.5 Hebei Tiancheng Pharmaceutical Latest Developments
13.10 Tai Yu Chemical & Pharmaceutical
  13.10.1 Tai Yu Chemical & Pharmaceutical Company Information
  13.10.2 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Tai Yu Chemical & Pharmaceutical Main Business Overview
  13.10.5 Tai Yu Chemical & Pharmaceutical Latest Developments
13.11 Tianjin Jinyao Pharmaceutical
  13.11.1 Tianjin Jinyao Pharmaceutical Company Information
  13.11.2 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Tianjin Jinyao Pharmaceutical Main Business Overview
  13.11.5 Tianjin Jinyao Pharmaceutical Latest Developments
13.12 Sunflower Pharmaceutical
  13.12.1 Sunflower Pharmaceutical Company Information
  13.12.2 Sunflower Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.12.3 Sunflower Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Sunflower Pharmaceutical Main Business Overview
  13.12.5 Sunflower Pharmaceutical Latest Developments
13.13 China Shineway Pharm
  13.13.1 China Shineway Pharm Company Information
  13.13.2 China Shineway Pharm Atropine Sulfate Injection Product Portfolios and Specifications
  13.13.3 China Shineway Pharm Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 China Shineway Pharm Main Business Overview
  13.13.5 China Shineway Pharm Latest Developments
13.14 CSPC Ouyi Pharmaceutical
  13.14.1 CSPC Ouyi Pharmaceutical Company Information
  13.14.2 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 CSPC Ouyi Pharmaceutical Main Business Overview
  13.14.5 CSPC Ouyi Pharmaceutical Latest Developments
13.15 Suicheng Pharmaceutical
  13.15.1 Suicheng Pharmaceutical Company Information
  13.15.2 Suicheng Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.15.3 Suicheng Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Suicheng Pharmaceutical Main Business Overview
  13.15.5 Suicheng Pharmaceutical Latest Developments
13.16 Chengdu Brilliant Pharmaceutical
  13.16.1 Chengdu Brilliant Pharmaceutical Company Information
  13.16.2 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Chengdu Brilliant Pharmaceutical Main Business Overview
  13.16.5 Chengdu Brilliant Pharmaceutical Latest Developments
13.17 Anhui Changjiang Pharmaceutical
  13.17.1 Anhui Changjiang Pharmaceutical Company Information
  13.17.2 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 Anhui Changjiang Pharmaceutical Main Business Overview
  13.17.5 Anhui Changjiang Pharmaceutical Latest Developments
13.18 Shanghai Harvest Pharmaceutical
  13.18.1 Shanghai Harvest Pharmaceutical Company Information
  13.18.2 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Shanghai Harvest Pharmaceutical Main Business Overview
  13.18.5 Shanghai Harvest Pharmaceutical Latest Developments
13.19 Hubei Xinghua Pharmaceutical
  13.19.1 Hubei Xinghua Pharmaceutical Company Information
  13.19.2 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
  13.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 Hubei Xinghua Pharmaceutical Main Business Overview
  13.19.5 Hubei Xinghua Pharmaceutical Latest Developments
13.20 Changzhou Pharmaceutical Factory
  13.20.1 Changzhou Pharmaceutical Factory Company Information
  13.20.2 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Product Portfolios and Specifications
  13.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.20.4 Changzhou Pharmaceutical Factory Main Business Overview
  13.20.5 Changzhou Pharmaceutical Factory Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Atropine Sulfate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Atropine Sulfate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5 mg/mL
Table 4. Major Players of 1 mg/ml
Table 5. Major Players of 5 mg/ml
Table 6. Major Players of Other
Table 7. Global Atropine Sulfate Injection Sales by Type (2021-2026) & (K Units)
Table 8. Global Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
Table 9. Global Atropine Sulfate Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Atropine Sulfate Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Atropine Sulfate Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Atropine Sulfate Injection Sale by Application (2021-2026) & (K Units)
Table 13. Global Atropine Sulfate Injection Sale Market Share by Application (2021-2026)
Table 14. Global Atropine Sulfate Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Atropine Sulfate Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Atropine Sulfate Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Atropine Sulfate Injection Sales by Company (2021-2026) & (K Units)
Table 18. Global Atropine Sulfate Injection Sales Market Share by Company (2021-2026)
Table 19. Global Atropine Sulfate Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Atropine Sulfate Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Atropine Sulfate Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Atropine Sulfate Injection Producing Area Distribution and Sales Area
Table 23. Players Atropine Sulfate Injection Products Offered
Table 24. Atropine Sulfate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Atropine Sulfate Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Atropine Sulfate Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Atropine Sulfate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Atropine Sulfate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Atropine Sulfate Injection Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Atropine Sulfate Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Atropine Sulfate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Atropine Sulfate Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Atropine Sulfate Injection Sales by Country (2021-2026) & (K Units)
Table 36. Americas Atropine Sulfate Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Atropine Sulfate Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Atropine Sulfate Injection Sales by Type (2021-2026) & (K Units)
Table 39. Americas Atropine Sulfate Injection Sales by Application (2021-2026) & (K Units)
Table 40. APAC Atropine Sulfate Injection Sales by Region (2021-2026) & (K Units)
Table 41. APAC Atropine Sulfate Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Atropine Sulfate Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Atropine Sulfate Injection Sales by Type (2021-2026) & (K Units)
Table 44. APAC Atropine Sulfate Injection Sales by Application (2021-2026) & (K Units)
Table 45. Europe Atropine Sulfate Injection Sales by Country (2021-2026) & (K Units)
Table 46. Europe Atropine Sulfate Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Atropine Sulfate Injection Sales by Type (2021-2026) & (K Units)
Table 48. Europe Atropine Sulfate Injection Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Atropine Sulfate Injection Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Atropine Sulfate Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Atropine Sulfate Injection Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Atropine Sulfate Injection Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Atropine Sulfate Injection
Table 54. Key Market Challenges & Risks of Atropine Sulfate Injection
Table 55. Key Industry Trends of Atropine Sulfate Injection
Table 56. Atropine Sulfate Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Atropine Sulfate Injection Distributors List
Table 59. Atropine Sulfate Injection Customer List
Table 60. Global Atropine Sulfate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Atropine Sulfate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Atropine Sulfate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Atropine Sulfate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Atropine Sulfate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Atropine Sulfate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Atropine Sulfate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Atropine Sulfate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Atropine Sulfate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Atropine Sulfate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Atropine Sulfate Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Atropine Sulfate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Atropine Sulfate Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Atropine Sulfate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Atropine Sulfate Injection Product Portfolios and Specifications
Table 76. Pfizer Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. American Regent Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. American Regent Atropine Sulfate Injection Product Portfolios and Specifications
Table 81. American Regent Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. American Regent Main Business
Table 83. American Regent Latest Developments
Table 84. Hikma Pharmaceuticals Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Hikma Pharmaceuticals Atropine Sulfate Injection Product Portfolios and Specifications
Table 86. Hikma Pharmaceuticals Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Hikma Pharmaceuticals Main Business
Table 88. Hikma Pharmaceuticals Latest Developments
Table 89. Apotex Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Apotex Atropine Sulfate Injection Product Portfolios and Specifications
Table 91. Apotex Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Apotex Main Business
Table 93. Apotex Latest Developments
Table 94. Amneal Pharmaceuticals Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Amneal Pharmaceuticals Atropine Sulfate Injection Product Portfolios and Specifications
Table 96. Amneal Pharmaceuticals Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Amneal Pharmaceuticals Main Business
Table 98. Amneal Pharmaceuticals Latest Developments
Table 99. Accord Healthcare Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Accord Healthcare Atropine Sulfate Injection Product Portfolios and Specifications
Table 101. Accord Healthcare Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Accord Healthcare Main Business
Table 103. Accord Healthcare Latest Developments
Table 104. China Res Double-Crane Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. China Res Double-Crane Atropine Sulfate Injection Product Portfolios and Specifications
Table 106. China Res Double-Crane Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. China Res Double-Crane Main Business
Table 108. China Res Double-Crane Latest Developments
Table 109. Hebei Kaiwei Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 111. Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Hebei Kaiwei Pharmaceutical Main Business
Table 113. Hebei Kaiwei Pharmaceutical Latest Developments
Table 114. Hebei Tiancheng Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 116. Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Hebei Tiancheng Pharmaceutical Main Business
Table 118. Hebei Tiancheng Pharmaceutical Latest Developments
Table 119. Tai Yu Chemical & Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 121. Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Tai Yu Chemical & Pharmaceutical Main Business
Table 123. Tai Yu Chemical & Pharmaceutical Latest Developments
Table 124. Tianjin Jinyao Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 126. Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Tianjin Jinyao Pharmaceutical Main Business
Table 128. Tianjin Jinyao Pharmaceutical Latest Developments
Table 129. Sunflower Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Sunflower Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 131. Sunflower Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sunflower Pharmaceutical Main Business
Table 133. Sunflower Pharmaceutical Latest Developments
Table 134. China Shineway Pharm Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. China Shineway Pharm Atropine Sulfate Injection Product Portfolios and Specifications
Table 136. China Shineway Pharm Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. China Shineway Pharm Main Business
Table 138. China Shineway Pharm Latest Developments
Table 139. CSPC Ouyi Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 141. CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. CSPC Ouyi Pharmaceutical Main Business
Table 143. CSPC Ouyi Pharmaceutical Latest Developments
Table 144. Suicheng Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 145. Suicheng Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 146. Suicheng Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Suicheng Pharmaceutical Main Business
Table 148. Suicheng Pharmaceutical Latest Developments
Table 149. Chengdu Brilliant Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 150. Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 151. Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Chengdu Brilliant Pharmaceutical Main Business
Table 153. Chengdu Brilliant Pharmaceutical Latest Developments
Table 154. Anhui Changjiang Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 155. Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 156. Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Anhui Changjiang Pharmaceutical Main Business
Table 158. Anhui Changjiang Pharmaceutical Latest Developments
Table 159. Shanghai Harvest Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 160. Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 161. Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Shanghai Harvest Pharmaceutical Main Business
Table 163. Shanghai Harvest Pharmaceutical Latest Developments
Table 164. Hubei Xinghua Pharmaceutical Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 165. Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Product Portfolios and Specifications
Table 166. Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Hubei Xinghua Pharmaceutical Main Business
Table 168. Hubei Xinghua Pharmaceutical Latest Developments
Table 169. Changzhou Pharmaceutical Factory Basic Information, Atropine Sulfate Injection Manufacturing Base, Sales Area and Its Competitors
Table 170. Changzhou Pharmaceutical Factory Atropine Sulfate Injection Product Portfolios and Specifications
Table 171. Changzhou Pharmaceutical Factory Atropine Sulfate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Changzhou Pharmaceutical Factory Main Business
Table 173. Changzhou Pharmaceutical Factory Latest Developments

LIST OF FIGURES

Figure 1. Picture of Atropine Sulfate Injection
Figure 2. Atropine Sulfate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atropine Sulfate Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Atropine Sulfate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Atropine Sulfate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Atropine Sulfate Injection Sales Market Share by Country/Region (2025)
Figure 10. Atropine Sulfate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5 mg/mL
Figure 12. Product Picture of 1 mg/ml
Figure 13. Product Picture of 5 mg/ml
Figure 14. Product Picture of Other
Figure 15. Global Atropine Sulfate Injection Sales Market Share by Type in 2026
Figure 16. Global Atropine Sulfate Injection Revenue Market Share by Type (2021-2026)
Figure 17. Atropine Sulfate Injection Consumed in Online Sales
Figure 18. Global Atropine Sulfate Injection Market: Online Sales (2021-2026) & (K Units)
Figure 19. Atropine Sulfate Injection Consumed in Offline Sales
Figure 20. Global Atropine Sulfate Injection Market: Offline Sales (2021-2026) & (K Units)
Figure 21. Global Atropine Sulfate Injection Sale Market Share by Application (2025)
Figure 22. Global Atropine Sulfate Injection Revenue Market Share by Application in 2026
Figure 23. Atropine Sulfate Injection Sales by Company in 2026 (K Units)
Figure 24. Global Atropine Sulfate Injection Sales Market Share by Company in 2026
Figure 25. Atropine Sulfate Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Atropine Sulfate Injection Revenue Market Share by Company in 2026
Figure 27. Global Atropine Sulfate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Atropine Sulfate Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Atropine Sulfate Injection Sales 2021-2026 (K Units)
Figure 30. Americas Atropine Sulfate Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Atropine Sulfate Injection Sales 2021-2026 (K Units)
Figure 32. APAC Atropine Sulfate Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Atropine Sulfate Injection Sales 2021-2026 (K Units)
Figure 34. Europe Atropine Sulfate Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Atropine Sulfate Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Atropine Sulfate Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Atropine Sulfate Injection Sales Market Share by Country in 2026
Figure 38. Americas Atropine Sulfate Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Atropine Sulfate Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Atropine Sulfate Injection Sales Market Share by Region in 2026
Figure 46. APAC Atropine Sulfate Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Atropine Sulfate Injection Sales Market Share by Application (2021-2026)
Figure 49. China Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Atropine Sulfate Injection Sales Market Share by Country in 2026
Figure 57. Europe Atropine Sulfate Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Atropine Sulfate Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Atropine Sulfate Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Atropine Sulfate Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Atropine Sulfate Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Atropine Sulfate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Atropine Sulfate Injection in 2026
Figure 74. Manufacturing Process Analysis of Atropine Sulfate Injection
Figure 75. Industry Chain Structure of Atropine Sulfate Injection
Figure 76. Channels of Distribution
Figure 77. Global Atropine Sulfate Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Atropine Sulfate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Atropine Sulfate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Atropine Sulfate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Atropine Sulfate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Atropine Sulfate Injection Revenue Market Share Forecast by Application (2027-2032)


More Publications